Nautilus Biotechnology
Priscilla Chen is an accomplished financial professional with extensive experience in corporate finance and reporting. Currently serving as Corporate Controller at Nautilus Biotechnology since August 2021, Priscilla previously held significant roles at ADP, where responsibilities included overseeing SEC filings as the Senior Director for Consolidations, Policy and External Reporting. Prior to ADP, Priscilla held key positions at PwC, including Director of Policy and External Reporting and Assurance Senior Manager, with a focus on audits for Fortune 100 and S&P 500 Pharmaceutical and biotech companies. Priscilla’s early career includes experience at PwC Belgium and internships with Johnson & Johnson, demonstrating a strong foundation in accounting derived from a Bachelor of Science in Accounting from Rutgers University.
This person is not in any offices
Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. They are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.